Cutaneous Side Effects and Transepidermal Water Loss To Gefitinib: A Study of 11 Patients

INTRODUCTION: Cutaneous side effects caused by epidermal growth factor receptor (EGFR) inhibitors occurred in 45–100% of patients which may lead to therapy modification or interruption. This study aimed to evaluate cutaneous side effects and transepidermal water loss (TEWL) values in non-small cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandra, Franky, Sandiono, Dendi, Sugiri, Unwati, Suwarsa, Oki, Gunawan, Hendra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336432/
https://www.ncbi.nlm.nih.gov/pubmed/28004308
http://dx.doi.org/10.1007/s13555-016-0163-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336432/
https://www.ncbi.nlm.nih.gov/pubmed/28004308
http://dx.doi.org/10.1007/s13555-016-0163-0

Ejemplares similares